Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

BSE: 537291

Small Cap

FMCG Sector

Retail Sector

₹166.42

+0.99

(+0.60%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nath Bio-Genes (India) Stock Performance

as on June 12, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹164.80
    ₹170.00
    downward going graph

    0.97%

    Downside

    2.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹126.15
    ₹238.69
    downward going graph

    24.20%

    Downside

    43.43%

    Upside

    downward going graph

Nath Bio-Genes (India) share price movements today

Previous Close
₹165.43
Open
₹165.43
Volume
17.43K
Upper Circuit
₹198.51
Lower Circuit
₹132.35
Day's Low - High
₹164.80 - ₹170.00
52 Week Low - High
₹126.15 - ₹238.69

Nath Bio-Genes (India) Historical Returns

1 Month Return
+ 3.42 %
3 Month Return
+ 17.98 %
1 Year Return
-18.12 %
3 Year Return
-12.13 %
5 Year Return
-59.14 %

Nath Bio-Genes (India) Fundamentals

as on June 12, 2026 at 4:01 pm IST

Market Cap

₹316.26 Cr

Return on Equity (ROE)

6.69

PE Ratio (TTM)

7.49

Return on capital employed (ROCE)

7.25

Industry PE ratio

48.48

Beta (LTM)

0.85

P/B Ratio

0.43

Dividend Yield

1.37

PEG Ratio

3.07

Quarterly Earnings Growth YOY

-100.68

EPS (TTM)

20.31

Book Value

339.08

Nath Bio-Genes (India) Stock Valuation

as on June 12, 2026 at 4:01 pm IST

Nath Bio-Genes (India) in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (7.49x)

June 12, 2026

Industry (48.48x)

June 12, 2026

Highest (11.85x)

August 4, 2023

LowHigh

Today’s Price to Earnings Ratio: 7.49x

Nath Bio-Genes (India) Technical Analysis

Track how Nath Bio-Genes (India) technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish12
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.07
Bullish
CCI (20)
139.29
Bearish
RSI (14)
69.77
Neutral
Momentum (10)
0.58
Bullish
ADI (14)
40.71
Bullish
Ultimate Oscillator (7,14,28)
58.28
Neutral

Moving Averages

Name

Value

Action

SMA (20)
167.07
Bullish
EMA (20)
167.2
Bullish
VWMA (20)
167.09
Bullish
SMA (50)
167.54
Bullish
EMA (50)
167.35
Bullish
SMA (200)
167.17
Bullish
EMA (200)
167.18
Bullish
KAMA (200)
166.89
Bullish
DEMA (200)
167.4
Bullish

Nath Bio-Genes (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes (India) with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nath Bio-Genes (India) Ltd image
Nath Bio-Genes (India) Ltd
NA316.26-11.83%0.5838364
Kriti Nutrients Ltd image
Kriti Nutrients Ltd
NA418.4117.32%0.5137734
GKB Ophthalmics Ltd image
GKB Ophthalmics Ltd
NA32.10-6.37%0.65-8108
KCK Industries Ltd image
KCK Industries Ltd
NA84.5930.67%0.00135
Standard Surfactants Ltd image
Standard Surfactants Ltd
NA41.566.58%0.001169
See all

Nath Bio-Genes (India) Stock’s Investor Sentiment and Interest

Search interest for Nath Bio-Genes (India) Ltd Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:43% versus previous 30 day period

Nath Bio-Genes (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
235.28
22.57
31.74
43.04
243.88
32.19
36.87
51.97
283.7
43.85
65.96
51.59
Other Income
0.12
0.06
2.54
1.36
0.13
0.08
0.48
4.4
3.83
4
4.42
3.63
Total Income
235.4
22.63
34.27
44.4
244.01
32.27
37.35
56.37
287.53
47.85
70.38
55.23
Expenses
198.25
17.59
26.09
39.11
207.34
27.38
28.84
51.55
245.42
37.75
62.39
47.12
Operating Profit
37.03
4.98
5.65
3.93
36.54
4.81
8.03
0.42
38.28
6.1
3.57
4.47
Operating Profit Margin %
15.74%
22.06%
17.8%
9.13%
14.98%
14.94%
21.78%
0.81%
13.49%
13.91%
5.41%
8.66%
Profit Before Interest, Tax and Depreciation
37.15
5.04
8.18
5.29
36.67
4.89
8.51
4.82
42.11
10.1
8
8.11
Interest
2.76
2.44
2.84
1.07
2.24
2.98
3.9
1.37
3.2
3.66
4.54
4.59
Depreciation
0.76
0.76
0.76
0.98
0.83
0.83
0.83
1.34
0.98
0.99
0.98
1.03
Profit Before Tax
33.63
1.84
4.58
3.24
33.6
1.08
3.78
2.11
37.93
5.45
2.48
2.49
Tax Paid
0.22
0.35
0.77
0.62
0.25
-0.03
1.14
0.63
0.66
0.64
0.87
2.5
Profit After Tax
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
4.82
1.6
-0.01
Total Net profit including share of profit / Loss from associate company
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
4.82
1.6
-0.01
EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.89
-0.79
Actual EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.89
-0.79
Adjusted EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.89
-0.79
Diluted EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.89
-0.79

Nath Bio-Genes (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
278.36
301.36
332.62
364.91
445.1
Other Income
1.85
0.55
4.08
5.09
13.82
Total Income
280.22
301.92
336.7
369.99
458.92
Expenses
329.96
252.62
282.76
315.11
392.66
Operating Profit
-51.6
48.74
49.86
49.8
52.44
Operating Profit Margin %
-18.54%
16.17%
14.99%
13.65%
11.78%
Profit Before Interest, Tax and Depreciation
-49.74
49.3
53.94
54.88
66.26
Interest
10.61
10.12
9.11
10.48
15.99
Depreciation
3.08
3.01
3.26
3.82
3.96
Profit Before Tax
-63.43
36.17
41.57
40.58
46.31
Tax Paid
3.95
1.15
1.95
1.98
4.67
Profit After Tax
-67.39
35.01
39.62
38.6
41.63
Total Net profit including share of profit / Loss from associate company
-67.39
35.01
39.62
38.6
41.63
EPS
-35.46
18.44
21.34
20.14
20.98
Actual EPS
-35.46
18.44
21.34
20.14
20.98
Adjusted EPS
-35.46
18.44
21.34
20.14
20.98
Diluted EPS
-35.46
18.44
21.34
20.14
20.98

Nath Bio-Genes (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.05
38.37
74.59
17.58
Cash Flow from Investing Activities
-19.86
-2.88
-27.41
-3.96
Cash Flow from Financing Activities
-22.23
-1.66
-7.78
-2.12
Net Cash Flow
-25.04
33.81
39.41
11.49

Nath Bio-Genes (India) Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
DII
4.37%
4.37%
4.37%
4.38%
4.37%
4.37%
3.94%
2.25%
0.76%
0.01%
0.01%
FII
0.22%
0%
0.27%
0.22%
0.19%
0.19%
0.21%
0.42%
0.32%
0.31%
0.23%
Public
49.81%
49.72%
49.76%
49.81%
49.85%
49.84%
50.25%
51.74%
53.32%
54.08%
54.17%
Total Outstanding Shares
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
Total Shareholders
34,365
34,263
35,132
35,834
35,423
35,056
34,911
34,207
34,122
33,550
33,031

Nath Bio-Genes (India) Corporate Actions

View detailed summary of the earnings and dividend history of Nath Bio-Genes (India).

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit fell -100.68% since last year same period to ₹0.01Cr in the Q4 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -100.63% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Nath Bio-Genes (India) Ltd Dividends April,2025

    In the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.40%.

    Read More about Dividends

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NATHBIOGEN stock has moved up by 3.5%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 54.08% to 54.17% in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 174.1% return, outperforming this stock by 187.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 39.7% return, outperforming this stock by 57.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 37.28 Cr → -0.01 Cr (in ₹), with an average decrease of 84.8% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.31% to 0.23% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 70.38 Cr → 55.23 Cr (in ₹), with an average decrease of 21.5% per quarter

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Revenue: ₹51.59Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.01Cr as on March 2026 (Q4 FY26)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
IndustryFMCG
E-voting on sharesClick here to vote

FAQs

What is Nath Bio-Genes (India) share price today?

Nath Bio-Genes (India) share price today stands at ₹166.42 as on at the close of the market. Nath Bio-Genes (India) share today touched a day high of ₹170 and a low of ₹164.8.

What is the 52 week high and 52 week low range for Nath Bio-Genes (India) share?

Nath Bio-Genes (India) touched a 52 week high of ₹238.69 and a 52 week low of ₹126.15. Nath Bio-Genes (India) share price today i.e. is closed at ₹166.42, which is -30.28% down from its 52 week high and 31.92% up from its 52 week low.

What is Nath Bio-Genes (India)'s market capitalisation today?

Nath Bio-Genes (India) market capitalisation is ₹316.26 Cr as on .

How to buy Nath Bio-Genes (India) shares?

To buy Nath Bio-Genes (India) shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATHBIOGEN or Nath Bio-Genes (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nath Bio-Genes (India) shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nath Bio-Genes (India) trading volume today?

Nath Bio-Genes (India) trading volume is 17.43K as on . This means that 17.43K shares of Nath Bio-Genes (India) were bought and sold on the stock market during today's trading session.